 | Form 4 Filings | Insider Buys | Significant Buys | Penny Stocks Insider Buying | Insider Sales |
| Insider Buy Sell Ratios | Stock Options | Insider Trading Stock Screener | Insider Trading Graph View | Insider Watch |
Insider Trading - Oyster Point Pharma Inc. (OYST)
| | "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise" - Peter Lynch What is insider trading>> |
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2019-11-04 Purchase | 2019-11-04 5:51 pm | Oyster Point Pharma Inc. | OYST | LINK WILLIAM J PHD Director 10% Owner | 27,500 | $16 | $440,000 | 2,002,298 (Indirect) | View |
| 2019-11-04 Purchase | 2019-11-04 5:54 pm | Oyster Point Pharma Inc. | OYST | Ozawa Clare Director | 562,500 | $16 | $9,000,000 | 1,003,658 (Indirect) | View |
| 2019-11-04 Purchase | 2019-11-04 5:58 pm | Oyster Point Pharma Inc. | OYST | Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC Versant Ventures IV LLC Versant Venture Capital IV L.P. Versant Side Fund IV L.P. 10% Owner | 590,000 | $16 | $9,440,000 | 1,003,658 (Indirect Direct) | View |
| 2019-11-04 Purchase | 2019-11-04 6:04 pm | Oyster Point Pharma Inc. | OYST | New Enterprise Associates 14 L.P. Sonsini Peter W. BARRIS PETER J NEA Partners 14 L.P. NEA 14 GP LTD BASKETT FOREST Florence Anthony A. Jr. MOTT DAVID M SANDELL SCOTT D 10% Owner | 935,000 | $16 | $14,960,000 | 5,925,287 (Direct) | View |
| 2019-11-04 Purchase | 2019-11-04 6:17 pm | Oyster Point Pharma Inc. | OYST | KKR Fund Holdings L.P. KRAVIS HENRY R ROBERTS GEORGE R KKR Management LLC KKR & Co. Inc. KKR Group Holdings Corp. KKR Fund Holdings GP Ltd 10% Owner | 155,000 | $16 | $2,480,000 | 1,039,622 (Indirect) | View |
| 2019-11-04 Purchase | 2019-11-04 6:19 pm | Oyster Point Pharma Inc. | OYST | Falcon Vision LLC KKR Healthcare Strategic Growth Fund L.P. KKR HCSG GP LLC KKR Associates HCSG L.P. 10% Owner | 155,000 | $16 | $2,480,000 | 1,039,622 (Indirect) | View |
| 2019-11-04 Purchase | 2019-11-04 7:04 pm | Oyster Point Pharma Inc. | OYST | Vida Ventures LLC 10% Owner | 185,000 | $16 | $2,960,000 | 963,468 (Direct) | View |
| 2019-11-04 Purchase | 2019-11-05 06:05 am | Oyster Point Pharma Inc. | OYST | Nau Jeffrey CEO | 1,000 | $16 | $16,000 | 1,000 (Indirect) | View |
| 2019-11-04 Purchase | 2019-11-05 06:08 am | Oyster Point Pharma Inc. | OYST | Lochner Daniel CFO | 6,300 | $16 | $100,800 | 6,300 (Direct) | View |
| 2019-11-04 Purchase | 2019-11-05 06:08 am | Oyster Point Pharma Inc. | OYST | Snisarenko John Chief Commercial Officer | 3,000 | $16 | $48,000 | 3,000 (Direct) | View |
| 2019-11-04 Purchase | 2019-11-06 4:30 pm | Oyster Point Pharma Inc. | OYST | InvOpps GP IV L.L.C. InvOpps IV L.P. InvOpps IV US L.P. LAINOVIC SACHA Director 10% Owner | 750,000 | $16 | $12,000,000 | 1,731,425 (Indirect) | View |
| 2020-05-19 Purchase | 2020-05-21 5:00 pm | Oyster Point Pharma Inc. | OYST | InvOpps GP IV L.L.C. InvOpps IV L.P. InvOpps IV US L.P. LAINOVIC SACHA Director 10% Owner | 178,571 | $28 | $4,999,988 | 1,850,818 (Indirect) | View |
| 2020-08-10 Purchase | 2020-08-11 4:03 pm | Oyster Point Pharma Inc. | OYST | Snisarenko John Chief Commercial Officer | 4,000 | $25.97 | $103,880 | 7,000 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2019-11-04 Conversion | 2019-11-04 5:47 pm | N/A N/A | Oyster Point Pharma Inc. | OYST | Ackermann Michael Director | 140,567 | $0 | 0 (Indirect) | View |
| 2019-11-04 Conversion | 2019-11-04 5:47 pm | N/A N/A | Oyster Point Pharma Inc. | OYST | Ackermann Michael Director | 140,567 | $0 | 0 (Indirect) | View |
| 2019-11-04 Conversion | 2019-11-04 5:50 pm | N/A N/A | Oyster Point Pharma Inc. | OYST | Murray Mark Anthony Director | 106,517 | $0 | 0 (Direct) | View |
| 2019-11-04 Conversion | 2019-11-04 5:50 pm | N/A N/A | Oyster Point Pharma Inc. | OYST | Murray Mark Anthony Director | 106,517 | $0 | 0 (Direct) | View |
| 2019-11-04 Conversion | 2019-11-04 5:51 pm | N/A N/A | Oyster Point Pharma Inc. | OYST | LINK WILLIAM J PHD Director 10% Owner | 10,420 | $0 | 2,002,298 (Indirect) | View |
| 2019-11-04 Conversion | 2019-11-04 5:51 pm | N/A N/A | Oyster Point Pharma Inc. | OYST | LINK WILLIAM J PHD Director 10% Owner | 1,654,359 | $0 | 2,002,298 (Indirect) | View |
| 2019-11-04 Conversion | 2019-11-04 5:51 pm | N/A N/A | Oyster Point Pharma Inc. | OYST | LINK WILLIAM J PHD Director 10% Owner | 955,392 | $0 | 2,002,298 (Indirect) | View |
| 2019-11-04 Conversion | 2019-11-04 5:51 pm | N/A N/A | Oyster Point Pharma Inc. | OYST | LINK WILLIAM J PHD Director 10% Owner | 10,420 | $0 | 2,002,298 (Indirect) | View |
| 2019-11-04 Conversion | 2019-11-04 5:51 pm | N/A N/A | Oyster Point Pharma Inc. | OYST | LINK WILLIAM J PHD Director 10% Owner | 1,654,359 | $0 | 2,002,298 (Indirect) | View |
| 2019-11-04 Conversion | 2019-11-04 5:51 pm | N/A N/A | Oyster Point Pharma Inc. | OYST | LINK WILLIAM J PHD Director 10% Owner | 955,392 | $0 | 2,002,298 (Indirect) | View |
| 2019-10-31 Option Award | 2019-11-04 5:52 pm | N/A N/A | Oyster Point Pharma Inc. | OYST | WEISNER AIMEE S Director | 23,125 | $0 | 23,125 (Direct) | View |
| 2019-11-04 Conversion | 2019-11-04 5:54 pm | N/A N/A | Oyster Point Pharma Inc. | OYST | Ozawa Clare Director | 1,941,500 | $0 | 1,003,658 (Indirect) | View |
| 2019-11-04 Conversion | 2019-11-04 5:54 pm | N/A N/A | Oyster Point Pharma Inc. | OYST | Ozawa Clare Director | 495,388 | $0 | 1,003,658 (Indirect) | View |
| 2019-11-04 Conversion | 2019-11-04 5:54 pm | N/A N/A | Oyster Point Pharma Inc. | OYST | Ozawa Clare Director | 566,158 | $0 | 1,003,658 (Indirect) | View |
| 2019-11-04 Conversion | 2019-11-04 5:54 pm | N/A N/A | Oyster Point Pharma Inc. | OYST | Ozawa Clare Director | 1,941,500 | $0 | 1,003,658 (Indirect) | View |
| 2019-11-04 Conversion | 2019-11-04 5:54 pm | N/A N/A | Oyster Point Pharma Inc. | OYST | Ozawa Clare Director | 495,388 | $0 | 1,003,658 (Indirect) | View |
| 2019-11-04 Conversion | 2019-11-04 5:54 pm | N/A N/A | Oyster Point Pharma Inc. | OYST | Ozawa Clare Director | 566,158 | $0 | 1,003,658 (Indirect) | View |
| 2019-11-04 Conversion | 2019-11-04 5:58 pm | N/A N/A | Oyster Point Pharma Inc. | OYST | Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC Versant Ventures IV LLC Versant Venture Capital IV L.P. Versant Side Fund IV L.P. 10% Owner | 10,420 | $0 | 1,003,658 (Indirect) | View |
| 2019-11-04 Conversion | 2019-11-04 5:58 pm | N/A N/A | Oyster Point Pharma Inc. | OYST | Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC Versant Ventures IV LLC Versant Venture Capital IV L.P. Versant Side Fund IV L.P. 10% Owner | 1,654,359 | $0 | 1,003,658 (Indirect) | View |
| 2019-11-04 Conversion | 2019-11-04 5:58 pm | N/A N/A | Oyster Point Pharma Inc. | OYST | Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC Versant Ventures IV LLC Versant Venture Capital IV L.P. Versant Side Fund IV L.P. 10% Owner | 1,941,500 | $0 | 1,003,658 (Direct) | View |
| 2019-11-04 Conversion | 2019-11-04 5:58 pm | N/A N/A | Oyster Point Pharma Inc. | OYST | Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC Versant Ventures IV LLC Versant Venture Capital IV L.P. Versant Side Fund IV L.P. 10% Owner | 495,388 | $0 | 1,003,658 (Direct) | View |
| 2019-11-04 Conversion | 2019-11-04 5:58 pm | N/A N/A | Oyster Point Pharma Inc. | OYST | Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC Versant Ventures IV LLC Versant Venture Capital IV L.P. Versant Side Fund IV L.P. 10% Owner | 566,158 | $0 | 1,003,658 (Indirect) | View |
| 2019-11-04 Conversion | 2019-11-04 5:58 pm | N/A N/A | Oyster Point Pharma Inc. | OYST | Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC Versant Ventures IV LLC Versant Venture Capital IV L.P. Versant Side Fund IV L.P. 10% Owner | 10,420 | $0 | 1,003,658 (Indirect) | View |
| 2019-11-04 Conversion | 2019-11-04 5:58 pm | N/A N/A | Oyster Point Pharma Inc. | OYST | Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC Versant Ventures IV LLC Versant Venture Capital IV L.P. Versant Side Fund IV L.P. 10% Owner | 1,654,359 | $0 | 1,003,658 (Indirect) | View |
| 2019-11-04 Conversion | 2019-11-04 5:58 pm | N/A N/A | Oyster Point Pharma Inc. | OYST | Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC Versant Ventures IV LLC Versant Venture Capital IV L.P. Versant Side Fund IV L.P. 10% Owner | 1,941,500 | $0 | 1,003,658 (Direct) | View |
| 2019-11-04 Conversion | 2019-11-04 5:58 pm | N/A N/A | Oyster Point Pharma Inc. | OYST | Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC Versant Ventures IV LLC Versant Venture Capital IV L.P. Versant Side Fund IV L.P. 10% Owner | 495,388 | $0 | 1,003,658 (Direct) | View |
| 2019-11-04 Conversion | 2019-11-04 5:58 pm | N/A N/A | Oyster Point Pharma Inc. | OYST | Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC Versant Ventures IV LLC Versant Venture Capital IV L.P. Versant Side Fund IV L.P. 10% Owner | 566,158 | $0 | 1,003,658 (Indirect) | View |
| 2019-11-04 Conversion | 2019-11-04 5:59 pm | N/A N/A | Oyster Point Pharma Inc. | OYST | Kleiner Perkins Caufield & Byers XIV LLC KPCB XIV Associates LLC KPCB XIV Founders Fund LLC 10% Owner | 45,529 | $0 | 0 (Direct) | View |
| 2019-11-04 Conversion | 2019-11-04 5:59 pm | N/A N/A | Oyster Point Pharma Inc. | OYST | Kleiner Perkins Caufield & Byers XIV LLC KPCB XIV Associates LLC KPCB XIV Founders Fund LLC 10% Owner | 45,529 | $0 | 0 (Direct) | View |
| 2019-11-04 Conversion | 2019-11-04 6:04 pm | N/A N/A | Oyster Point Pharma Inc. | OYST | New Enterprise Associates 14 L.P. Sonsini Peter W. BARRIS PETER J NEA Partners 14 L.P. NEA 14 GP LTD BASKETT FOREST Florence Anthony A. Jr. MOTT DAVID M SANDELL SCOTT D 10% Owner | 3,606,282 | $0 | 5,925,287 (Direct) | View |
| 2019-11-04 Conversion | 2019-11-04 6:04 pm | N/A N/A | Oyster Point Pharma Inc. | OYST | New Enterprise Associates 14 L.P. Sonsini Peter W. BARRIS PETER J NEA Partners 14 L.P. NEA 14 GP LTD BASKETT FOREST Florence Anthony A. Jr. MOTT DAVID M SANDELL SCOTT D 10% Owner | 1,061,547 | $0 | 5,925,287 (Direct) | View |
| 2019-11-04 Conversion | 2019-11-04 6:04 pm | N/A N/A | Oyster Point Pharma Inc. | OYST | New Enterprise Associates 14 L.P. Sonsini Peter W. BARRIS PETER J NEA Partners 14 L.P. NEA 14 GP LTD BASKETT FOREST Florence Anthony A. Jr. MOTT DAVID M SANDELL SCOTT D 10% Owner | 3,606,282 | $0 | 5,925,287 (Direct) | View |
| 2019-11-04 Conversion | 2019-11-04 6:04 pm | N/A N/A | Oyster Point Pharma Inc. | OYST | New Enterprise Associates 14 L.P. Sonsini Peter W. BARRIS PETER J NEA Partners 14 L.P. NEA 14 GP LTD BASKETT FOREST Florence Anthony A. Jr. MOTT DAVID M SANDELL SCOTT D 10% Owner | 1,061,547 | $0 | 5,925,287 (Direct) | View |
| 2019-11-04 Conversion | 2019-11-04 6:17 pm | N/A N/A | Oyster Point Pharma Inc. | OYST | KKR Fund Holdings L.P. KRAVIS HENRY R ROBERTS GEORGE R KKR Management LLC KKR & Co. Inc. KKR Group Holdings Corp. KKR Fund Holdings GP Ltd 10% Owner | 884,622 | $0 | 1,039,622 (Indirect) | View |
| 2019-11-04 Conversion | 2019-11-04 6:17 pm | N/A N/A | Oyster Point Pharma Inc. | OYST | KKR Fund Holdings L.P. KRAVIS HENRY R ROBERTS GEORGE R KKR Management LLC KKR & Co. Inc. KKR Group Holdings Corp. KKR Fund Holdings GP Ltd 10% Owner | 884,622 | $0 | 1,039,622 (Indirect) | View |
| 2019-11-04 Conversion | 2019-11-04 6:19 pm | N/A N/A | Oyster Point Pharma Inc. | OYST | Falcon Vision LLC KKR Healthcare Strategic Growth Fund L.P. KKR HCSG GP LLC KKR Associates HCSG L.P. 10% Owner | 884,622 | $0 | 1,039,622 (Indirect) | View |
| 2019-11-04 Conversion | 2019-11-04 6:19 pm | N/A N/A | Oyster Point Pharma Inc. | OYST | Falcon Vision LLC KKR Healthcare Strategic Growth Fund L.P. KKR HCSG GP LLC KKR Associates HCSG L.P. 10% Owner | 884,622 | $0 | 1,039,622 (Indirect) | View |
| 2019-11-04 Conversion | 2019-11-04 7:04 pm | N/A N/A | Oyster Point Pharma Inc. | OYST | Vida Ventures LLC 10% Owner | 778,468 | $0 | 963,468 (Direct) | View |
| 2019-11-04 Conversion | 2019-11-04 7:04 pm | N/A N/A | Oyster Point Pharma Inc. | OYST | Vida Ventures LLC 10% Owner | 778,468 | $0 | 963,468 (Direct) | View |
| 2019-11-04 Conversion | 2019-11-05 06:05 am | N/A N/A | Oyster Point Pharma Inc. | OYST | OYSTER POINT PHARMA I LLC 10% Owner | 955,392 | $0 | 0 (Direct) | View |
| 2019-11-04 Conversion | 2019-11-05 06:05 am | N/A N/A | Oyster Point Pharma Inc. | OYST | OYSTER POINT PHARMA I LLC 10% Owner | 955,392 | $0 | 0 (Direct) | View |
| 2019-11-04 Conversion | 2019-11-06 4:30 pm | N/A N/A | Oyster Point Pharma Inc. | OYST | InvOpps GP IV L.L.C. InvOpps IV L.P. InvOpps IV US L.P. LAINOVIC SACHA Director 10% Owner | 609,965 | $0 | 1,731,425 (Indirect) | View |
| 2019-11-04 Conversion | 2019-11-06 4:30 pm | N/A N/A | Oyster Point Pharma Inc. | OYST | InvOpps GP IV L.L.C. InvOpps IV L.P. InvOpps IV US L.P. LAINOVIC SACHA Director 10% Owner | 1,230,050 | $0 | 1,731,425 (Indirect) | View |
| 2019-11-04 Conversion | 2019-11-06 4:30 pm | N/A N/A | Oyster Point Pharma Inc. | OYST | InvOpps GP IV L.L.C. InvOpps IV L.P. InvOpps IV US L.P. LAINOVIC SACHA Director 10% Owner | 609,965 | $0 | 1,731,425 (Indirect) | View |
| 2019-11-04 Conversion | 2019-11-06 4:30 pm | N/A N/A | Oyster Point Pharma Inc. | OYST | InvOpps GP IV L.L.C. InvOpps IV L.P. InvOpps IV US L.P. LAINOVIC SACHA Director 10% Owner | 1,230,050 | $0 | 1,731,425 (Indirect) | View |
| 2020-02-03 Option Award | 2020-02-05 4:10 pm | N/A 2030-02-02 | Oyster Point Pharma Inc. | OYST | Lochner Daniel CFO | 72,648 | $32.65 | 72,648 (Direct) | View |
| 2020-02-03 Option Award | 2020-02-05 4:11 pm | N/A 2030-02-02 | Oyster Point Pharma Inc. | OYST | Snisarenko John Chief Commercial Officer | 72,648 | $32.65 | 72,648 (Direct) | View |
| 2020-02-03 Option Award | 2020-02-05 4:11 pm | N/A 2030-02-02 | Oyster Point Pharma Inc. | OYST | Nau Jeffrey CEO | 211,533 | $32.65 | 211,533 (Direct) | View |
| 2020-06-08 Option Award | 2020-06-10 9:12 pm | N/A N/A | Oyster Point Pharma Inc. | OYST | Ackermann Michael Director | 14,805 | $0 | 152,162 (Direct) | View |
| 2020-06-08 Option Award | 2020-06-10 9:14 pm | N/A N/A | Oyster Point Pharma Inc. | OYST | Murray Mark Anthony Director | 6,600 | $0 | 115,047 (Direct) | View |
| 2020-06-08 Option Award | 2020-06-10 9:15 pm | N/A N/A | Oyster Point Pharma Inc. | OYST | LINK WILLIAM J PHD Director | 6,600 | $0 | 6,600 (Direct) | View |
| 2020-06-08 Option Award | 2020-06-10 9:16 pm | N/A N/A | Oyster Point Pharma Inc. | OYST | Tsai Benjamin Director | 6,600 | $0 | 6,600 (Direct) | View |
| 2020-06-08 Option Award | 2020-06-10 9:17 pm | N/A N/A | Oyster Point Pharma Inc. | OYST | WEISNER AIMEE S Director | 6,600 | $0 | 29,725 (Direct) | View |
| 2020-06-08 Option Award | 2020-06-10 9:17 pm | N/A N/A | Oyster Point Pharma Inc. | OYST | Behbahani Ali Director | 6,600 | $0 | 6,600 (Direct) | View |
| 2020-06-08 Option Award | 2020-06-10 9:18 pm | N/A N/A | Oyster Point Pharma Inc. | OYST | Ozawa Clare Director | 6,600 | $0 | 6,600 (Direct) | View |
| 2020-07-28 Exercise | 2020-07-30 7:37 pm | N/A N/A | Oyster Point Pharma Inc. | OYST | Nau Jeffrey CEO | 5,000 | $1.02 | 514,774 (Direct) | View |
| 2020-07-28 Exercise | 2020-07-30 7:37 pm | N/A 2027-11-10 | Oyster Point Pharma Inc. | OYST | Nau Jeffrey CEO | 5,000 | $1.02 | 514,774 (Direct) | View |
| 2020-08-11 Exercise | 2020-08-12 8:32 pm | N/A N/A | Oyster Point Pharma Inc. | OYST | Lochner Daniel CFO | 4,000 | $11.51 | 197,950 (Direct) | View |
| 2020-08-11 Exercise | 2020-08-12 8:32 pm | N/A 2029-07-25 | Oyster Point Pharma Inc. | OYST | Lochner Daniel CFO | 4,000 | $11.51 | 197,950 (Direct) | View |
| 2020-08-11 Exercise | 2020-08-18 6:18 pm | N/A N/A | Oyster Point Pharma Inc. | OYST | Lochner Daniel CFO | 4,000 | $11.51 | 10,300 (Direct) | View |
| 2020-09-25 Exercise | 2020-09-28 6:12 pm | N/A N/A | Oyster Point Pharma Inc. | OYST | Lochner Daniel CFO | 4,000 | $11.51 | 193,950 (Direct) | View |
| 2020-09-25 Exercise | 2020-09-28 6:12 pm | N/A 2029-07-25 | Oyster Point Pharma Inc. | OYST | Lochner Daniel CFO | 4,000 | $11.51 | 193,950 (Direct) | View |